Fetal-maternal bleeding associated with genetic amniocentesis.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Clinical Chemistry

Background:

• Genetic amniocentesis is a common prenatal diagnostic procedure.
• Maternal serum alpha-fetoprotein (AFP) levels can be affected by various factors during pregnancy.
• Fetal-to-maternal bleeding (FMB) is a potential complication of invasive prenatal procedures.

Purpose of the Study:

• To evaluate maternal serum AFP elevation post-genetic amniocentesis as an indicator of fetal-to-maternal bleeding (FMB).
• To assess the correlation between post-procedure AFP levels, placental location, and pregnancy outcomes.
• To determine the significance of FMB in relation to spontaneous abortion rates and Rh sensitization.

Main Methods:

• Prospective study of 333 consecutive patients undergoing genetic amniocentesis.
• Preliminary placental localization by ultrasound and pre-procedure serum AFP measurement.
• Post-procedure serial AFP measurements and monitoring for spontaneous abortion.

Main Results:

• An elevated post-AFP was observed in 8.4% of patients, suggesting FMB.
• A significantly higher rate of spontaneous abortion was noted in patients with post-AFP elevation (14.29%) compared to those without (0.98%).
• Anterior placental implantation was more frequent in patients with post-AFP elevation, indicating a potential risk factor.

Conclusions:

• Maternal serum AFP elevation following genetic amniocentesis is a reliable indicator of fetal-to-maternal bleeding.
• Preliminary ultrasound placental localization is important for counseling patients on amniocentesis risks.
• Findings have implications for Rh immunoglobulin prophylaxis and managing pregnancy outcomes after amniocentesis.